真诚的突破:通过心力衰竭治疗的突破性进展提高生活质量
Ramprakash Devadoss1, Gagandeep Dhillon2, Pranjal Sharma3
1Carle Methodist Hospital, Peoria, IL 61636, USA.
Journal of cardiovascular development and disease
|January 22, 2024
概括
心力衰竭影响全球数以百万计的人,需要多学科的护理. 药理治疗和医疗器械的最新进展为这种日益增长的心血管疾病提供了改进的管理策略.
科学领域:
- 心脏病学 心脏病学
- 心血管医学 心血管医学
- 医疗技术 医疗技术 医学技术
背景情况:
- 心力衰竭 (HF) 是一个重要的全球健康问题,影响全球5600万人,并导致大量的发病率和死亡率.
- 患病率上升与人口老龄化和生活方式因素有关,增加了患者和医疗保健系统的负担.
- 有效的HF管理需要全面的方法,包括药物,生活方式的改变,以及先进的医疗干预.
研究的目的:
- 审查心力衰竭 (HF) 治疗和预防方面的显著药理和基于设备的进展.
- 探索新兴技术和新的治疗策略来管理HF.
- 突出人工智能在高频检测和患者护理中的作用.
主要方法:
- 对心力衰竭的当前药理疗法的审查,包括血管新生素受体-尼普利辛抑制剂,SGLT2抑制剂和GLP-1激动剂.
- 讨论既有和新型基于设备的干预措施,如心脏再同步疗法,心脏收缩度调节,机械循环支持和跨导管干预措施.
- 探索未来的方向,包括基于CRISPR的基因疗法和AI在高频管理中的应用.
主要成果:
- 在药理治疗方面取得了重大进展,为心力衰竭患者提供了新的治疗途径.
- 先进的设备疗法为患有晚期心力衰竭的患者提供了关键的选择,改善了结果和生活质量.
- 新兴技术和人工智能对早期检测和更个性化的管理策略充满希望.
结论:
- 心力衰竭领域正在迅速发展,具有创新的药理和基于设备的治疗方法.
- 未来的进展,包括基因疗法和人工智能,预计将进一步彻底改变心力衰竭护理.
- 一种多学科和前性的方法对于应对日益增长的心力衰竭负担至关重要.
更多相关视频
07:24Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
Published on: April 8, 2013
24.3K
14:24Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
11.7K
相关概念视频
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
432
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
432
01:22Heart Failure Drugs: Diuretics
384
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
384
01:22Heart Failure Drugs: β-Blockers
341
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
341
01:26Heart Failure Drugs: Inotropic Agents
591
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
591
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K